Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP9X activates AMOT. 4 / 4

| 4

➶

reach

"These findings are consistent with a model in which USP9x mediated deubiquitylation increases AMOT stability."

27462448

➶

reach

"Moreover, previous studies showed that USP9X targets Angiomotin (AMOT) and Angiomotin like 2 (AMOTL2), which in turn regulates YAP1 activation XREF_BIBR, XREF_BIBR."

29449692

➶

reach

"Moreover, USP9X was reported to target Angiomotin (AMOT) and Angiomotin like 2 (AMOTL2), which in turn regulates YAP1 activation XREF_BIBR, XREF_BIBR."

29449692

➶

reach

"USP9x targets AMOT and AMOT like proteins."

27462448

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP9X activates AMOT. 4 / 4

Our Sources:

Databases

Reading